-
Mashup Score: 0Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern - 2 hour(s) ago
Injectable HIV antiretroviral therapy (ART) is starting to be provided in England with several hundred patients now on the two-monthly injections. The British HIV Association’s Spring Conference in Birmingham last week heard some of the first data from the rollout in England. In general, the injections are effective and liked by patients, though there have been a few withdrawals.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2
“After I left the clinic, I got very emotional. Not because I had monkeypox…But I felt let down by the way the discourse, and the way that the infection, the virus or whatever it is, was being portrayed as well. It took me to a place where I just didn’t expect to feel in terms of my experience, as a gay man, with lots of privilege in lots of ways. Usually I felt like I had dignity in the [health] service and the way I am treated by the government and the likes of that. And it just kind of really sped away suddenly.”
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 20Sex toys and the risk of HIV transmission - 1 day(s) ago
The risk of sharing sex toys varies according to whether they are covered with condoms, and whether they’re properly cleaned between use with different partners
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 37
Having a hidden infection with hepatitis B may undermine viral suppression after a switch to dolutegravir / lamivudine (Dovato), a study of people with HIV who simplified treatment in Italian and French clinics has concluded. The study investigators recommend careful monitoring of hepatitis B activity and HIV suppression in anyone with markers suggesting a hidden hepatitis B infection – antibodies to hepatitis B core antigen without corresponding antibodies to the hepatitis B surface antigen.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 41A class of HIV drugs might protect against Alzheimer’s - 2 day(s) ago
A cohort of people with HIV who took NRTIs (a class of HIV drugs) as part of HIV treatment showed lower rates of Alzheimer’s disease than people without HIV. The team of American researchers behind this study published in the journal of Pharmaceuticals suspect HIV-like sequences in our genome to be associated with the disease and thus these HIV drugs protect against its development.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2Diabetes and HIV - 5 day(s) ago
Rates of diabetes are higher in people living with HIV than in the general population. Changes to your lifestyle can reduce your risk of type 2 diabetes
Source: www.aidsmap.comCategories: General Medicine News, HIV/AIDSTweet
-
Mashup Score: 65Drugs that make HIV-infected cells self-destruct induce profound viral load drops in mice after just one or two doses - 5 day(s) ago
Last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2024) included the latest information about potential drugs and treatments that might lead to a cure. Two presentations included promising data on TACK (targeted activation of cell kill). This is a property of some drugs in the non-nucleoside reverse transcriptase (NNRTI) family which induces a chain of events leading to the self-destruction of HIV-infected cells.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 16Stigma has a profound impact on the mental and physical health of Indian women with HIV - 6 day(s) ago
Women living with HIV in West Bengal (an eastern state of India) face intersectional stigma due to HIV as well as their other marginalised identities such as being a widow or a sex worker. This impacts not only their mental health, but also their physical health and leads to poorer HIV treatment outcomes, according to a qualitative study published in PLOS Global Health by Dr Reshmi Mukerji of University College London and colleagues.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Among migrants in Europe, the risk of contracting HIV or developing AIDS is exacerbated by the many social vulnerabilities they face in their daily lives. Furthermore, these vulnerabilities intersect and are embedded in sexism, cisgenderism and racism. This is illustrated by three case-studies from a Swiss sociological and qualitative study recently published in Culture, Health and Sexuality.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 16Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance - 8 day(s) ago
HIV clinicians have issued a note of caution regarding long-acting injectable cabotegravir and rilpivirine in a recent commentary in AIDS. Dr Diego Ripamonti of the Papa Giovanni XXIII hospital in Bergamo and colleagues from the universities of Milan and Siena highlight that people with long treatment histories in particular may not be good candidates for the treatment, due to the substantial risk of developing resistance to the drugs should the treatment fail.
Source: www.aidsmap.comCategories: General Medicine News, Infectious DiseaseTweet
Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern https://t.co/uQwCGl61h6 https://t.co/E42JHZ8yHj